Effects of ACL Reconstruction Surgery on Vertical Jump

Anterior cruciate ligament (ACL) injuries are one of the most common injuries involving lower extremities among athletes. Due to the severity of the injury and the invasive procedure in reconstructing the ligament, ACL injuries can have a significant impact on muscular strength, flexibility, and endurance. The purpose of this study was to examine differences in ground reaction force (GRF) between lower extremities of subjects who have undergone unilateral ACL reconstructive surgery. Of particular interest is the subjects’ predisposal to future injuries resulting from significant disparities of produced forces between lower extremities and, consequently, the resulting disruption of the body’s kinetic chain. Ten collegiate athletes (n=10) were used for the study: Five having undergone no prior surgery involving lower extremities (control group) and five having undergone unilateral ACL reconstructive surgery (experimental group). Tests were conducted in the Biomechanics’ Laboratory using the force plate to measure GRF (Newtons). Each subject completed a total of 10 vertical jumps: Five jumps were completed with only one leg on the force plate for measurement (GRF), and then five jumps were completed with only the opposite leg on the force plate for measurement (GRF). For the experimental group, the reconstructed leg was tested first, ruling out fatigue as a contributor for the expected decreased force production. Upon completion, subject’s jumps were averaged and combined with their respective groups. A grand mean then was calculated for each group and used for discussion of results. Obtained data exhibited significant differences of force produced between surgically repaired and non-surgically repaired extremities. For the control group, differences were minimal on both the upward and downward phase of the jump, with an average disparity of 5 percent and 7 percent, respectively. For the experimental group, however, the non-reconstructed extremity demonstrated significantly more force on both the upward and downward phase of the jump, with an average disparity of 130 percent and 140 percent, respectively. It can be assumed these imbalances are not only occurring during explosive movements such as the vertical jump; yet, they occur during everyday activities such as walking, standing, sitting, etc. When dealing with such imbalances, the body makes compensatory changes that disrupt the body’s kinetic chain. Over time, these disruptions can manifest into chronic injuries resulting from muscular strength and flexibility imbalances, improper movement patterns, and postural deviations—not to mention, the probability of a traumatic injury also is greatly increased due to the aforementioned problems

Feasibility study of portable technology for weight loss and HbA1c control in type 2 diabetes

Background The study investigated the feasibility of conducting a future Randomised Controlled Trial (RCT) of a mobile health (mHealth) intervention for weight loss and HbA1c reduction in Type 2 Diabetes Mellitus (T2DM). Methods The intervention was a small wearable mHealth device used over 12 weeks by overweight people with T2DM with the intent to lose weight and reduce their HbA1c level. A 4 week maintenance period using the device followed. The device records physical activity level and information about food consumption, and provides motivational feedback based on energy balance. Twenty-seven participants were randomised to receive no intervention; intervention alone; or intervention plus weekly motivational support. All participants received advice on diet and exercise at the start of the study. Weight and HbA1c levels were recorded at baseline and weeks 6, 12, and 16. Qualitative interviews were conducted with participants who received the intervention to explore their experiences of using the device and involvement in the study including the training received. Results Overall the device was perceived to be well-liked, acceptable, motivational and easy to use by participants. Some logistical changes were required during the feasibility study, including shortening of the study duration and relaxation of participant inclusion criteria. Descriptive statistics of weight and HbA1c data showed promising trends of weight loss and HbA1c reduction in both intervention groups, although this should be interpreted with caution. Conclusions A number of methodological recommendations for a future RCT emerged from the current feasibility study. The mHealth device was acceptable and promising for helping individuals with T2DM to reduce their HbA1c and lose weight. Devices with similar features should be tested further in larger studies which follow these methodological recommendations

Epigenetic management of major psychosis

Epigenetic mechanisms are thought to play a major role in the pathogenesis of the major psychoses (schizophrenia and bipolar disorder), and they may be the link between the environment and the genome in the pathogenesis of these disorders. This paper discusses the role of epigenetics in the management of major psychosis: (1) the role of epigenetic drugs in treating these disorders. At present, there are three categories of epigenetic drugs that are being actively investigated for their ability to treat psychosis: drugs inhibiting histone deacetylation; drugs decreasing DNA methylation; and drugs targeting microRNAs; and (2) the role of epigenetic mechanisms in electroconvulsive therapy in these disorders

Photochemical fingerprinting Is a sensitive probe for the detection of synthetic cannabinoid receptor agonists; toward robust point-of-care detection

With synthetic cannabinoid receptor agonist (SCRA) use still prevalent across Europe and structurally advanced generations emerging, it is imperative that drug detection methods advance in parallel. SCRAs are a chemically diverse and evolving group, which makes rapid detection challenging. We have previously shown that fluorescence spectral fingerprinting (FSF) has the potential to provide rapid assessment of SCRA presence directly from street material with minimal processing and in saliva. Enhancing the sensitivity and discriminatory ability of this approach has high potential to accelerate the delivery of a point-of-care technology that can be used confidently by a range of stakeholders, from medical to prison staff. We demonstrate that a range of structurally distinct SCRAs are photochemically active and give rise to distinct FSFs after irradiation. To explore this in detail, we have synthesized a model series of compounds which mimic specific structural features of AM-694. Our data show that FSFs are sensitive to chemically conservative changes, with evidence that this relates to shifts in the electronic structure and cross-conjugation. Crucially, we find that the photochemical degradation rate is sensitive to individual structures and gives rise to a specific major product, the mechanism and identification of which we elucidate through density-functional theory (DFT) and time-dependent DFT. We test the potential of our hybrid “photochemical fingerprinting” approach to discriminate SCRAs by demonstrating SCRA detection from a simulated smoking apparatus in saliva. Our study shows the potential of tracking photochemical reactivity via FSFs for enhanced discrimination of SCRAs, with successful integration into a portable device

Selective and Irreversible Inhibitors of Aphid Acetylcholinesterases: Steps Toward Human-Safe Insecticides

Aphids, among the most destructive insects to world agriculture, are mainly controlled by organophosphate insecticides that disable the catalytic serine residue of acetylcholinesterase (AChE). Because these agents also affect vertebrate AChEs, they are toxic to non-target species including humans and birds. We previously reported that a cysteine residue (Cys), found at the AChE active site in aphids and other insects but not mammals, might serve as a target for insect-selective pesticides. However, aphids have two different AChEs (termed AP and AO), and only AP-AChE carries the unique Cys. The absence of the active-site Cys in AO-AChE might raise concerns about the utility of targeting that residue. Herein we report the development of a methanethiosulfonate-containing small molecule that, at 6.0 µM, irreversibly inhibits 99% of all AChE activity extracted from the greenbug aphid (Schizaphis graminum) without any measurable inhibition of the human AChE. Reactivation studies using β-mercaptoethanol confirm that the irreversible inhibition resulted from the conjugation of the inhibitor to the unique Cys. These results suggest that AO-AChE does not contribute significantly to the overall AChE activity in aphids, thus offering new insight into the relative functional importance of the two insect AChEs. More importantly, by demonstrating that the Cys-targeting inhibitor can abolish AChE activity in aphids, we can conclude that the unique Cys may be a viable target for species-selective agents to control aphids without causing human toxicity and resistance problems

Watershed features and stream water quality: Gaining insight through path analysis in a Midwest urban landscape, U.S.A.

Urban stream condition is often degraded by human activities in the surrounding watershed. Given the complexity of urban areas, relationships among variables that cause stream degradation can be difficult to isolate. We examined factors affecting stream condition by evaluating social, terrestrial, stream hydrology and water quality variables from 20 urban stream watersheds in central Iowa, U.S.A. We used path analysis to examine and quantify social and ecological factors related to variation in stream conditions. Path models supported hypotheses that stream water quality was influenced by variables in each category. Specifically, one path model indicated that increased stream water conductivity was linked to high road density, which itself was associated with high human population density. A second path model revealed nitrogen concentration in stream water was positively related to watershed area covered by cropland, and that cropland increased as human population density declined. A third path model indicated phosphorus concentration in stream water declined as percent of watershed residents with college education increased, although the mechanism underlying this relationship was unclear and could have been an artifact of lower soil-derived nutrient input from watersheds dominated by paved surfaces. To improve environmental conditions in urban streams, land use planning strategies should include limiting or reducing road density near streams, installing treatment trains for surface water runoff associated with roads, and establishing vegetated buffer zones to reduce inputs of road salt and other pollutants. Additionally, education/outreach should be conducted with residents to increase understanding of how their own behaviors influence stream water quality.This article is from Landscape and Urban Planning 143 (2015): 219, doi: 10.1016/j.landurbplan.2015.08.001.</p

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome